Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 15/100

Termination Rate

0.0%

0 terminated out of 10 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

71%

5 of 7 completed with results

Key Signals

5 with results100% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (8)
P 3 (1)
P 4 (1)

Trial Status

Completed7
Recruiting1
Withdrawn1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (10)

Research Network

Activity Timeline